Schrodinger Stock
Computational drug design
Sign up today and learn more about Schrodinger Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Schrodinger Stock
Schrödinger is a scientific developer of computational drug design for pharmaceutical and biotechnology research.
Investors
Baron Capital Management
Bill & Melinda Gates Foundation
Apeel Sciences, Pivot Bio, Butterfly Network, Schrodinger, Evolve Biosystems, Heliogen
Cascade Investment
Convoy, Delos, Schrodinger, OANDA Corporation, Ginkgo Bioworks
Deerfield
GV
Uber, Robinhood, Jet, Impossible Foods, Lacework, Slack, Snyk, SambaNova Systems, DocuSign, Gusto
Qiming Venture Partners
WuXi AppTec
Funding History
| April 2010 | $10.0M |
|---|---|
| December 2012 | $20.0M |
| June 2015 | $22.0M |
| January 2019 | $85.0M |
Management
Chief Biomedical Scientist
Karen Akinsanya
Chief Financial Officer
Joel Lebowitz
Chief Business Officer
Cony D'Cruz
Press
Fast Company - Sep, 25 2015
The Tangled History And Mysterious Legality Of "Happy Birthday"techweekeurope - Sep, 4 2015
Intel Invests £33m In Quantum Computing Researchgizmodo - Jul, 13 2015
The Material That Both Conducts Electricity – and Doesn’tgizmodo - May, 25 2015
You'll Feel Way Smarter After Watching These YouTube Physics LessonsEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
